{"DataElement":{"publicId":"2714601","version":"1","preferredName":"Child-Pugh Classification Prothrombin Time Score","preferredDefinition":"Numeric value that is a grade for the Prothrombin time (seconds prolonged) or Prothrombin time INR measurement of the Child-Pugh Classification (CPC), used to assess the prognosis of chronic liver disease, mainly cirrhosis. [Manually-curated]","longName":"CPC_PT_INR_SC","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2714547","version":"1","preferredName":"Child-Pugh Classification Measurement Score","preferredDefinition":"Used to assess the prognosis of chronic liver disease, mainly cirrhosis. Although it was originally used to predict mortality during surgery, it is now used to determine the prognosis, as well as the required strength of treatment and the necessity of liver transplantation._Annotation used to indicate that the size or magnitude of something was determined by comparison to a standard._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"CPC_MSRMT_SC","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2714544","version":"1","preferredName":"Child-Pugh Classification","preferredDefinition":"Used to assess the prognosis of chronic liver disease, mainly cirrhosis. Although it was originally used to predict mortality during surgery, it is now used to determine the prognosis, as well as the required strength of treatment and the necessity of liver transplantation.","longName":"C71469","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Child-Pugh Classification","conceptCode":"C71469","definition":"Used to assess the prognosis of chronic liver disease, mainly cirrhosis. Although it was originally used to predict mortality during surgery, it is now used to determine the prognosis, as well as the required strength of treatment and the necessity of liver transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"414A406F-C958-3C88-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-14","modifiedBy":"ONEDATA","dateModified":"2007-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2714545","version":"1","preferredName":"Measurement Score","preferredDefinition":"Measurement; the size or magnitude of something.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C25209:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Measurement","conceptCode":"C25209","definition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"414A406F-C969-3C88-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-14","modifiedBy":"ONEDATA","dateModified":"2007-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"414A406F-C97A-3C88-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-14","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2714570","version":"1","preferredName":"Child-Pugh Classification Prothrombin Time Score","preferredDefinition":"Used to assess the prognosis of chronic liver disease, mainly cirrhosis. Although it was originally used to predict mortality during surgery, it is now used to determine the prognosis, as well as the required strength of treatment and the necessity of liver transplantation.__A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"CPC_PTINR_SC","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"3","valueDescription":">6 (PT) or > 2.3 (PT INR)","ValueMeaning":{"publicId":"2714571","version":"1","preferredName":">6 (PT) or > 2.3 (PT INR)","longName":"2714571","preferredDefinition":">6 Prothrombin time (seconds prolonged) or >2.3 Prothrombin time INR","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4149FA4B-2F5F-6143-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4149FA4B-2F78-6143-E044-0003BA3F9857","beginDate":"2007-12-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-14","modifiedBy":"REEVESD","dateModified":"2007-12-14","deletedIndicator":"No"},{"value":"2","valueDescription":"<4 - 6 (PT) or 1.7 - 2.3 (PT INR)","ValueMeaning":{"publicId":"2714572","version":"1","preferredName":"<4 - 6 (PT) or 1.7 - 2.3 (PT INR)","longName":"2714572","preferredDefinition":"4 - 6 Prothrombin time (seconds prolonged) or 1.7 - 2.3 Prothrombin time INR","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4149FA4B-2F84-6143-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4149FA4B-2F9D-6143-E044-0003BA3F9857","beginDate":"2007-12-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-14","modifiedBy":"REEVESD","dateModified":"2007-12-14","deletedIndicator":"No"},{"value":"1","valueDescription":"<4 (PT) or < 1.7 (PT INR)","ValueMeaning":{"publicId":"2714573","version":"1","preferredName":"<4 (PT) or < 1.7 (PT INR)","longName":"2714573","preferredDefinition":"<4 Prothrombin time (seconds prolonged) or <1.7 Prothrombin time INR","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4149FA4B-2FA9-6143-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4149FA4B-2FC2-6143-E044-0003BA3F9857","beginDate":"2007-12-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-14","modifiedBy":"REEVESD","dateModified":"2007-12-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2524082","version":"1","preferredName":"Person Measure/Instrument Testing","preferredDefinition":"Process and results associated with self-reported measures and instruments, surveys, other tools","longName":"MEASURE/INSTRUMENT TESTING","context":"CCR","contextVersion":"1","origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1E838B40-6636-0A25-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-09-28","modifiedBy":"REEVESD","dateModified":"2008-11-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2714569","version":"1","preferredName":"Child-Pugh Classification Prothrombin Time Score","preferredDefinition":"Used to assess the prognosis of chronic liver disease, mainly cirrhosis. Although it was originally used to predict mortality during surgery, it is now used to determine the prognosis, as well as the required strength of treatment and the necessity of liver transplantation.:A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C71469:C62656:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Child-Pugh Classification","conceptCode":"C71469","definition":"Used to assess the prognosis of chronic liver disease, mainly cirrhosis. Although it was originally used to predict mortality during surgery, it is now used to determine the prognosis, as well as the required strength of treatment and the necessity of liver transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Prothrombin Time","conceptCode":"C62656","definition":"A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4149FA43-EEF8-5FCC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-14","modifiedBy":"ONEDATA","dateModified":"2007-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4149FA43-EF09-5FCC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-14","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812726","version":"1","longName":"U Nebraska Med Center","context":"NCIP"},{"publicId":"2812870","version":"1","longName":"UNMC New CDEs","context":"NCIP"}]}],"AlternateNames":[{"name":"DCP","type":"USED_BY","context":"DCP"}],"ReferenceDocuments":[{"name":"Prothrombin time (sec prolong","type":"Preferred Question Text","description":"Prothrombin time (sec prolonged) or PT INR","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"415C05E9-B960-2856-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-15","modifiedBy":"LUY","dateModified":"2013-10-22","changeDescription":"Curated to support Nebraska adoption of C3D","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}